Try our Advanced Search for more refined results
Life Sciences - May, 2024
272 articles
- Caremark Cut Loose From CVS Price-Gouging Case
- Samsung Strikes First With Smart Ring IP Suit Against Oura
- PTAB Upholds Medtronic Bladder Control Patents On Remand
- COVID Test Contract Suit 'Cries Out' For Jury, NC Judge Says
- 9th Circ. COVID 'Cure' Case Shows Perks Of Puffery Defense
- FTC Focus: Exploring The Meaning Of Orange Book Letters
- Weight Loss Drug Caused Stomach Paralysis, Suit Says
- Beasley Allen Wants J&J Subpoenas Nixed Amid Ethics Fight
- New Antibody IP Ruling Still Needs To Be Tested In Courts
- Investors Can Aid In The Acceptance Of Psychedelic Medicine
- In Rarity, 1 Party's Judges Gain 100% Control Of Circuit Bench
- FDA Seeks Fines Over Elf Bar E-Cigarette Sales
- Warren Pushes To Clinch 'Popular' Drug Patent 'March-In' Plan
- Exec Found Liable For 'Shadow Trading' Seeks New Trial
- Rite Aid Ch. 11 Timeline Extended To Allow More Plan Review
- 'South Park'-Quoting Judge Says CEO Can't 'Blame Canada'
- What To Watch As The FTC Targets Drug Patent Listings
- Class Actions At The Circuit Courts: May Lessons
- Pa. Court Blocks State's Recall Over Cannabis Vape Additives
- Ozempic Maker Says Texas Pharmacy Selling Knockoff Drug
- Trauma-Informed Legal Approaches For Pro Bono Attorneys
- 3M Nixes Teva Inhaler Patent On Appeal At EPO
- Ex-Sidley Atty To Lead Faegre's West Coast Class Action Team
- NY Attys Back Bid For Justices To Hear Double-Patenting Row
- South Baltimore Citizens Call On EPA For Incinerator Relief
- FDA Sued Over Controversial Lab Test Rule
- Israeli Nanotech Startup, Canadian Biotech Plot US IPOs
- Chicago IP Firm Accused Of Botching Fetal Biotech Patent
- Wilson Sonsini Adds 2 Attys In Salt Lake City From Kirkland
- Gibson Dunn, Skadden Guide $3B Merck-EyeBio Deal
- 3 Firms Build $627M Take-Private Sale Of Medical Device Biz
- Greenberg Traurig Adds IP Atty From Eversheds Sutherland
- Whistleblower Counsel Can't Get 'Exorbitant' $11.5M Fee
- Playing Music Makes Me A Better Lawyer
- Abbott, Dexcom Call For New Glucose Monitor Patent Trial
- J&J To Pay $1.25B For Global Rights To Eczema Treatment
- HIV Drug Buyers Fight Bid To Combine 9th Circ. Appeal Briefs
- Catching Up With Delaware's Chancery Court
- Ga. Dental Imaging Co. Fights To Keep X-Ray IP Suit Alive
- Edwards Urges Full Fed. Circ. To Limit FDA Safe Harbor
- Beasley Allen, J&J Trade Barbs Over DQ Bid In Talc Litigation
- Proposed Cannabis Reschedule Sidesteps State Law Effects
- How Attys Can Avoid Pitfalls When Withdrawing From A Case
- Esperion Launches Suits Over Cholesterol Drug Patents
- Treaty Wants Patents To Cite Ties To 'Traditional Knowledge'
- Petition Watch: Forum Shopping, Monopolies & Gun Safety
- Fla. Lab Owner Will Pay $27M To End False Billing Suit
- Shuttered Paper Mill Flouted $12M Incentive Deal, NC AG Says
- NY AG Sues Over Illegal Long Island Wetland Construction
- Biden's Judicial Impact And What's Left On The Wish List
- NYSE Companies Could Face Heat If Business Focus Changes
- UK Litigation Roundup: Here's What You Missed In London
- Using A Children's Book Approach In Firm Marketing Content
- NJ Justices Toss Direct Appeals Over Hospital Contract Bid
- Fed. Circ. Upends Inventors' Interference Win Over Time-Bar
- A Changing Regulatory Landscape For Weight Loss Drugs
- Opioid Suits Offer Case Study In Abatement Expert Testimony
- Ex-Judge Pushed False Narrative On Atty Romance, Firm Says
- Patent Lessons From 4 Federal Circuit Reversals In April
- Merck To Pay $600M For KKR-Backed Life Sciences Biz
- Just 57% Of Complex Global Deals Closed Since 2020
- J&J Loses Expedited Bid For Beasley Allen Docs In Talc MDL
- GSK, Boehringer Prevail In 1st Zantac Cancer Trial
- Inventor To Take $102M IP Malpractice Row To Ga. High Court
- Cancer Patients Target J&J Talc Unit's Asset Shuffles
- Justices' CFPB Alliance May Save SEC Courts, Not Chevron
- FDA Must Act On Sexual Side Effects Of SSRIs, Suit Says
- USPTO's Proposed Disclaimer Rule Would Harm Inventors
- Evidence Shaky In First Zantac Cancer Trial, Drugmakers Say
- Doc Gets 3 Mos. For Alexion Trades Despite 'Meaningful Job'
- DuPont 'Document Dump' Rattles NC In PFAS Suit
- Stryker Agrees To Settle Calif. Misclassification Suit
- MilliporeSigma Avoids Charges As DOJ Extols Self-Disclosure
- Teva, Bristol-Myers Cite Bystolic Against Cancer Drug Case
- Being An EMT Makes Me A Better Lawyer
- Dickinson Adds Ex-Sheppard Mullin IP Pro In Silicon Valley
- Lead Blood Test Maker To Plead Guilty, Pay $42M Over Defects
- Covington Reps As Biogen Makes $1.8B Bet On HI-Bio
- Hawaii Wins $916M From Bristol-Myers, Sanofi Over Plavix
- Ex-AUSA Blames Inexperience For Outcome Forfeiture Error
- Sens. Challenge Pharma Lobbyist Over Patent Abuse
- DC Circ. Says Drugmakers Can Limit Pharmacy Discounts
- MetLife Workers Tell 3rd Circ. Higher Premiums Give Standing
- CohnReznick Adds PwC Partner To International Tax Practice
- SPAC Investor's Suit Changes Came Too Late, Chancery Rules
- PE Firms Close Separate Funds With Nearly $1.3B Total In Tow
- Cooley Atty Returns From Deputy GC In-House Role In Boston
- Strategic Hiring Was The New Normal For BigLaw In 2023
- The Law360 400: Tracking The Largest US Law Firms
- Paul Hastings' FDA Chair Departs For Arnold & Porter
- Ex-IRS Agent, Five Others Sentenced In COVID Fraud Scheme
- Lab Says GSK Hid Zantac Cancer Risk From Feds For Decades
- Teladoc Faces Suit Over Mental Health Platform's Losses
- Ultragenyx Must Face Suit Over Use Of Henrietta Lacks' Cells
- USPTO Clarifies Means-Plus-Function Claims For Antibodies
- McKinsey Can't Nix Pregnant Women's Claims In Opioid MDL
- Judge Tosses Acuitas' COVID Biotech IP Suit
- Local Governments Seek Sanctions For PBMs In Opioid MDL
- iRhythm Brass Face Suit Over FDA's Heart Monitor Inquiry
- Mitigating Incarceration's Impacts On Foreign Nationals
- Contract Disputes Recap: Saying What Needs To Be Said
- J&J Says Beasley Allen Looking To 'Bias' Vote On $6.5B Plan
- Latham Hires 2 Skadden Healthcare Partners In DC
- Catching Up With Delaware's Chancery Court
- Ga. Judge OKs $5M Atty Fees In $41M Acella Thyroid Deal
- Moderna Fends Off Pfizer's MRNA Patent Challenge
- Shah Ends Novavax Proxy Fight Following Sanofi Deal
- VA Deal Winner Says Protest Not Based On Common Sense
- Allergan Says Deserted Drug Rule Weakens $680M Fraud Suit
- Patent Office Gets Another Earful About 'March-In' Plan
- Pfizer Unit Wins $107.5M Patent Verdict Against AstraZeneca
- FCA Relators Seek Finders Fee For SpineFrontier Doc Deals
- Judge Won't Bar Thermo Fisher Exec's Jump To Repligen
- EndoStim Emerges From Delaware Insolvency Proceeding
- Industry Emboldened After Justices Galvanize Agency Attacks
- Texas Justices Let Fen-Phen Atty Malpractice Fight Roll On
- Winston & Strawn Leads Asia-Focused SPAC $100M IPO
- UK Litigation Roundup: Here's What You Missed In London
- Ointment Scheme Conned Gov't Out Of Millions, Fla. Suit Says
- 3rd Circ. Shuns Teva's 'Novel' Appeal On Israeli Investor Class
- FTC Deputy Director Rao On Healthcare Antitrust Agenda
- NJ Judge Scrutinizes J&J Unit's Libel Claim Over Talc Study
- IQVIA To Pay $3.5M To Resolve Ex-Workers' 401(k) Suit
- Ex-Pharma Exec Cops To Contempt For Barred Finance Work
- Gilead, Teva Want 17 HIV Drug Antitrust Appeals Consolidated
- Lessons On Challenging Class Plaintiffs' Expert Testimony
- Exploring An Alternative Model Of Litigation Finance
- Pa. Pot Co. Says No Deal To Breach In Growth IP Suit
- $5.5M Apotex Generic Drug Price-Fixing Deal Gets Initial OK
- Del. IP Ruling May Mark Limitation-By-Limitation Analysis Shift
- HUD Calls Pa. Medical Marijuana Housing Suit Premature
- Biden Admin Proposes To Loosen Restrictions On Marijuana
- 'Excellent' Altria MDL Deal Earns Attys Fees Above Benchmark
- Lilly Lands Default ITC Order Against Weight Loss Copycats
- Feds, Pesticide Cos. Seek More Time To Find Mediator
- Anthem Blue Cross Owes $3.8M For COVID Tests, Lab Says
- Cell Therapy Cos. Must Beware Limits Of Patent Safe Harbors
- AstraZeneca Sales Reps Win Early Cert. In Gender Bias Suit
- Monsanto's $23M False Ad Deal Challenged At 9th Circ.
- Former Sandoz Executive Avoids Prison In Price-Fixing Case
- Teaching Yoga Makes Me A Better Lawyer
- How Clinical Trials Affect Patentability In US And Europe
- Biotech Co. Sued In Del. For Faulty Election, Share Hike Vote
- The PREP Immunity Question Won't Be Decided Yet
- Norwich, Bausch Ask Fed. Circ. To Rethink Xifaxan IP Ruling
- Calif. City Sues Dow, Shell Over TCP-Tainted Water
- Vein Tech Maker Faces Investor Suit Over DOJ Kickback Probe
- Jury's $2M Medical Device Infringement Verdict Upended
- States Accuse EEOC Of 'Smuggling' Abortion Into PWFA Rule
- Biotech Co. Hits Bankruptcy With Creditor Deal In Hand
- Congressional IP Attorneys Keeping Close Watch On AI
- Mich. AG Says Eli Lilly 'Cherry-Picking' Enforcement Data
- A Vision For Economic Clerkships In The Legal System
- Shire Settles Claims Over Alleged ADHD Generic Delay
- State-Regulated Cannabis Can Thrive Without Section 280E
- Key Takeaways From FDA Final Rule On Lab-Developed Tests
- Chinese Drug Co. Sanctioned After 'Tortuous' 3-Year Info Fight
- USPTO Eyes Change To Patent Applicants' Disclaimer Practice
- Biogen Investors Seek Class Cert. In Alzheimer's Drug Suit
- 2nd Circ. Affirms Dismissal Of Bystolic Antitrust Suit
- SEC Says Biotech Co., Atty Should Pay $14M For Investor Lies
- Assessing HHS' Stance On Rare Disease Patient Assistance
- Ga. Dental Imaging Co. Pushes For Ax Of X-Ray IP Row
- Ex-Police Chief Gets 3 Months For Alexion Insider Trading
- Calif. Jury Awards Ex-UCLA Doctor $14M In 2nd Bias Trial
- Philips Wants Cleaner Co. To Chip In For $1B CPAP Deal
- Feds' Biotech Enforcement Efforts Are Too Heavy-Handed
- McCarter & English Aims To Sink Biotech Malpractice Suit
- 'Prolific' Asbestos Injury Firm Accused Of Fraud, Racketeering
- Haynes Boone Lands Procopio Life Sciences Leader In Calif.
- Retail Group Opposes $1B Arbitral Award Against Walgreens
- Pharma Cos., FDA Debate 'Same Drug' In Orphan Drug Case
- Lab Exec Sentenced For Deadly Fungal Meningitis Outbreak
- Pharmaceutical Cos. Can't Nix Parkinson's Drug Antitrust Suit
- Regulating Resurrected Species Under The ESA
- E-Discovery Quarterly: Recent Rulings On Text Message Data
- What CRA Deadline Means For Biden Admin. Rulemaking
- Fox Rothschild Hires Ex-Seed IP Trio On The West Coast
- No 'Piecemeal' Fees For Infant Data Win Amid 6th Circ. Appeal
- Sanofi, Novavax Sign $1.2B Deal For One-Shot COVID, Flu Jab
- Fed. Circ. Lifts Ban On Generic Cos.' Bladder Drugs
- Judge Clarifies Gilead Didn't Directly Infringe HIV Drug IP
- First Zantac Trial Plaintiff Says She Can't Live Normal Life
- Judge Halts DEA's Hearing On Proposed Psychedelics Ban
- Masimo Makes Offer To End Activist Politan's Proxy Contest
- Fed. Circ. Skeptical Allergan Illegally Extended Exclusivity
- 5 Takeaways From FDA's Biosimilars Promotion Guidance
- Ex-Dental Device CEO Cops To $10.7M Investor Fraud
- Ex-Official Says NJ, Ethics Board Are 'Stonewalling' Discovery
- Dual-Track IPO-M&A Exit Strategies For Life Science Cos.
- Body-Sculpting Device Supplier Hit With Fraud Claims
- 11th Circ. Rejects Monsanto's Roundup Suit Redo Request
- Does Expert Testimony Aid Preliminary IPR Responses?
- Ex-Pharma Exec Asks 1st Circ. To DQ Judge In Contempt Case
- Apnea Device Maker ProSomnus Gets OK For Ch. 11 Loan
- Deals Rumor Mill: Paramount, Peloton, International Paper
- Quinn Emanuel Atty Says Asset Freeze Hurt Outcome Defense
- Opioid Maker Beats Investor Suit Over FDA Warning For Good
- Are Concessions In FDA's Lab-Developed Tests Rule Enough?
- Shockwave Medical Investor Challenges $13B Deal With J&J
- Conn. Justices To Hear McCarter & English Damages Demand
- Kirkland Drives Vance Street To $775M Fund IV Closing
- Double-Patenting Ruling Shows Terminal Disclaimers' Value
- Swimming Makes Me A Better Lawyer
- Sleep Apnea Co. Hits Ch. 11 Over $41.5M In Debt, Cash Woes
- Simpson Thacher-Led Silver Lake Lands $20.5B For 7th Fund
- GOP Reps. Want IP Enforcers To Get Tougher On Infringers
- Iceberg Image Closes Pacira Drug Patent Infringement Trial
- Pharma Co. Falsely Touted Obesity Drug Results, Suit Claims
- Fed. Circ. Seems Wary Of Broad's CRISPR Inventorship Win
- Colo. Judge Tells Cos. Their Warring Briefs Aren't Helping
- Mid-2024 FCA Enforcement And Litigation Trends To Watch
- Fla. Schools And Hospitals Fight To Save Opioid Claims
- Gov't Seeks Early Win In Ga. Medicaid Expansion Suit
- NJ Law Firm Scores Exit In Benicar MDL Fees Suit
- Prepetition Waivers Sway Invitae Judge On Kirkland Hire
- 1st Circ. Questions SEC Walk-Back In Conn. Atty's Fraud Case
- What 100 Federal Cases Suggest About Changes To Chevron
- Law Firm Must Face COVID Test-Kit Fraud Suit, NJ Court Told
- Birth Control Cos. Can't Dodge Conn. Injury Suit, Court Told
- US Thrashes Mexico's 'Inaccurate' Portrayal Of GMO Corn
- Biotech Co. Wants To Appeal Red Cross Antitrust Immunity
- Warranty Claims Trimmed From Bone Graft Tuberculosis Suit
- Chickasaw Can't Reopen Optum Prescription Payback Suit
- Paul Weiss Lands M&A Pro Who Sees Strong Deals Pipeline
- Why High Court May Have Rejected IP Obviousness Appeal
- Catching Up With Delaware's Chancery Court
- SEC Settles Insider Info Charges With CBD Co.'s Ex-Chairman
- Microplastics At The Crossroads Of Regulation And Litigation
- Mintz Adds Proskauer Life Sciences IP Litigation Team
- Ala. High Court Won't Rethink Decision On Frozen Embryos
- FTC Requests Additional Info On $16.5B Novo-Catalent Deal
- Publix Can't Send Questions To Ga. Justices In Opioid Suit
- Medical Testing Co. Not In Health Field For Taxes, IRS Says
- 4th Circ. Preview: Hemp, Wells And A Withdrawal
- UK Litigation Roundup: Here's What You Missed In London
- The Fed. Circ. In April: Hurdles Remain For Generics
- 6 States Strike $270M Opioid Deal With Amneal
- 7th Circ. Mostly Backs Ill. Home Health Kickbacks Judgment
- Endo Judge Hopes Criminal Sentence Warns Opioid Makers
- Walgreens Fights $1B Arb. Award Over COVID Test Contract
- Feds Call Out Gilead's Efforts To Revise HIV Drug IP Judgment
- Masimo Hit With Derivative Suit Over Audio Co. Acquisition
- Latham, Skadden Grab Spotlight As Large IPOs Surge In April
- Email Exchanges Doom Honeywell Bid To Nix $20M GSA Claim
- Pharma. Co. Wants Ex-Director To Stop Poaching Customers
- Calif. Justices To Review Gilead's HIV Drug Negligence Fight
- State Legislators Urge Feds To Change Cannabis' Status
- Tylenol MDL Highlights Expert Admissibility Headaches
- Recent BigLaw Moves Show Boston Is 'Clearly On The Map'
- 4th Circ. Revives Workers' Suit Over SC Plant Explosion
- Schumer Reups Call For His Judge Shopping Bill
- Plaintiff To Share 'Horrific' Story In First Zantac Cancer Trial
- Skin Care Drug Co. Gets OK For Ch. 11 Wind-Down Plan
- Freshfields-Led Novartis Inks $1.75B Cancer Drug Co. Buyout
- Don't Use The Same Template For Every Client Alert
- 3 Takeaways From The DOJ's Cannabis Recommendation
- Dental Supply Co. Must Face Suit Over COVID-Era Woes
- Bayer Can't Scratch Off Antitrust Suit Over Flea, Tick Meds
- Median Patent Damages Awards Are Shrinking
- Eiger Gets Deal With Merck Over $46M Rare-Disease Drug Sale
- 3rd Circ. Flags Bayer's Knowledge Of Tainted Fungal Spray
- 'Foul' BioVentrix Cash-Out Gets Extra Scrutiny, Chancery Says
- J&J Unit Cuts Deal To End Cancer Drug Trade Secret Fight
- 5th Circ. Judge Skeptical Of Medicare Drug 'Price-Setting'
- Don't Fall On That Hill: Keys To Testifying Before Congress
- Online Portal Helps Fortify Feds' Unfair Health Practices Fight
- Insulin Pump Maker Wins Toss of Investor Suit For Now
- Attys Say $5M Fee In Acella Settlement A Modest Proposal
- AI Is Top Of Mind For Companies — And Securities Regulators
- Walking With My Dog Makes Me A Better Lawyer
- J&J Proposes $6.5B Deal To End Ovarian Cancer Claims